Herantis Pharma Oyj : Managers’ Transactions – Mats Heiman

Herantis Pharma Plc

Company release 30 Oct 2020 at 9:00 am EET

Herantis Pharma Oyj – Managers’ Transactions

Herantis Pharma Plc
Company release 30 Oct 2020 at 9:00 am

____________________________________________

Person subject to the notification requirement

Name: Heiman, Mats

Position: Closely associated person

(1): Person Discharging Managerial Responsibilities In Issuer

Name: Atteryd Heiman, Ingrid

Position: Member of the Board

Issuer: Herantis Pharma Oyj

LEI: 743700W4CQVYAT3WKK38

Notification type: INITIAL NOTIFICATION

Reference number: 743700W4CQVYAT3WKK38_20201029220801_12

____________________________________________

Transaction date: 2020-09-18

Venue: FIRST NORTH FINLAND (FNFI)

Instrument type: SHARE

ISIN: FI4000087861

Nature of the transaction: DISPOSAL

Transaction details

(1): Volume: 4,584 Unit price: 7.7 EUR

Aggregated transactions

(1): Volume: 4,584 Volume weighted average price: 7.7 EUR

____________________________________________

Transaction date: 2020-10-01

Venue: FIRST NORTH FINLAND (FNFI)

Instrument type: SHARE

ISIN: FI4000087861

Nature of the transaction: DISPOSAL

Transaction details

(1): Volume: 3,888 Unit price: 6.86 EUR

Aggregated transactions

(1): Volume: 3,888 Volume weighted average price: 6.86 EUR

____________________________________________

Transaction date: 2020-10-02

Venue: FIRST NORTH FINLAND (FNFI)

Instrument type: SHARE

ISIN: FI4000087861

Nature of the transaction: DISPOSAL

Transaction details

(1): Volume: 1,584 Unit price: 6.92 EUR

Aggregated transactions

(1): Volume: 1,584 Volume weighted average price: 6.92 EUR

______________________________________

Further information:

Julie Silber/Gabriela Urquilla

Tel: +46 (0)7 93 486 277/+46 (0)72-396 72 19

Email:ir@herantis.com

Certified Advisor: UB Securities Ltd, Finland: +358 9 25 380 225, Sweden: +358 40 5161400

Company website: www.herantis.com

Distribution:

Main media
www.herantis.com